Rejuve.AI is the research arm of SingularityNET (AGIX), the leading artificial intelligence (AI) protocol in the crypto market. They aim to use advanced bio-AI and aggregated data to create longevity solutions, while also rewarding individuals who contribute data to the research process.
This project is built by renowned academics in the biotech field, and is backed by various strategic partners including top crypto firms and medical organizations. They are solving real-world issues with blockchain and AI solutions. In this article, we will explain what Rejuve.AI is, and why $RJV should be on your 2023 watch list.
What is Rejuve.AI?
Rejuve.AI is an AI-driven longevity research network that aims to create a decentralized network of researchers, clinics, and data contributors to develop affordable and accessible solutions against aging. By leveraging a live and interactive research database, people can measure and track their health data, while earning rewards for their contributions.
Its Longevity App is currently in beta, and the final iteration is expected to launch at the end of Q1 or early Q2. For more information on the app, check out their website.
Why Rejuve.AI Matters
Rejuve.AI seeks to address the current limitations of the longevity market. Traditionally, longevity products have been accessible only to the wealthy. Additionally, big tech companies frequently gather data through our everyday devices, but the people who contribute this data rarely see any direct benefits. However, Rejuve.AI has come up with a unique tokenomic model that accurately assigns credit to people who contribute to longevity research, regardless of their background or financial status.
Meanwhile, another key problem with health data is that it’s often controlled by third parties who profit from selling it without consent. Rejuve.AI solves this issue through blockchain technology, which allows users to share their data securely and privately for research purposes. Compensation will be given to users for resulting discoveries, and researchers can also contribute and receive compensation. Rejuve.AI is the future of longevity research and a win-win for both contributors and researchers.
Who is the Team behind Rejuve.AI?
Rejuve.AI was co-founded by Jasmine Smith, Dr. Deborah Duong, and Dr. Ben Goertzel. They are distinguished biotech professionals who have accomplished many notable milestones:
- Jasmine Smith (CEO) – Former Senior Medical Coder at Memorial Hermann Health System, worked with SingularityNET for nearly four years.
- Dr. Deborah Duong (CTO) – Has decades of experience with AI and simulation modeling for medicine, NLP, social networks, national security and more. In 1995, her Master’s thesis on the world’s first adaptive agent-based social simulation was published in the journal, Behavioral Sciences.
- Dr. Ben Goertzel (Chief AI Scientist) – CEO and founder of SingularityNET, former Chief Scientist of Hanson Robotics, helped develop AI models for the National Institutes of Health (NIH) and US Centers for Disease Control and Prevention (CDC), published 25+ books and 150+ research papers on biotech and AI.
Does Rejuve.AI have a Token?
Yes, Rejuve.AI is launching its $RJV token on Ethereum and Cardano. Its first round of token generation event (TGE) has ended, and the second round starts at 15th March, 12:00 UTC and ends at 16th March, 11:59 UTC.
$RJV Token Utilities
The $RJV token provides access to science-based health products and services, while also contributing more data to the app platform. It also serves as a decision-making tool for members in key topics, issues, and events in the network’s governance.
By performing certain tasks through the Longevity mobile app, individuals can earn $RJV. In the first phase of tasks, these include completing health surveys and inventories, connecting wearable health trackers, and will soon expand to lab test reports. According to the road map, there are plans to include participation in studies and clinical trials in the future.
$RJV Tokenomics
The total supply of $RJV is 1 billion tokens. During the TGE, Rejuve.AI will mint 647,916,667 RJV-ETH tokens on Ethereum and 352,083,333 RJV-ADA tokens on Cardano. The circulating supply at TGE will be 66,833,333 RJV with an initial market cap of $1,002,500. The private placement rate is $0.0125 and the public rate, community and DEX is $0.015. $RJV holders will be able to choose which blockchain they want to use for their transactions, just like SingularityNET AGIX and NuNet NTX tokens.
